Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Long Term DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CureVac N.V (CVAC) Raw Materials: 2019-2021

Historic Raw Materials for CureVac N.V (CVAC) over the last 3 years, with Dec 2021 value amounting to $64.2 million.

  • CureVac N.V's Raw Materials rose 290.74% to $64.2 million in Q4 2021 from the same period last year, while for Dec 2021 it was $64.2 million, marking a year-over-year increase of 290.74%. This contributed to the annual value of $64.2 million for FY2021, which is 290.74% up from last year.
  • Latest data reveals that CureVac N.V reported Raw Materials of $64.2 million as of FY2021, which was up 290.74% from $16.4 million recorded in FY2020.
  • CureVac N.V's Raw Materials' 5-year high stood at $64.2 million during FY2021, with a 5-year trough of $6.8 million in FY2019.
  • Over the past 3 years, CureVac N.V's median Raw Materials value was $16.4 million (recorded in 2020), while the average stood at $29.2 million.
  • Data for CureVac N.V's Raw Materials shows a peak YoY surged of 290.74% (in 2021) over the last 5 years.
  • Over the past 3 years, CureVac N.V's Raw Materials (Yearly) stood at $6.8 million in 2019, then surged by 140.47% to $16.4 million in 2020, then surged by 290.74% to $64.2 million in 2021.